Since ages plants with therapeutic effects are used for curing several human ailments. With the development in modern biotechnological tools, these therapeutic compounds could be overexpressed in the plants. This review aims to compile the valuable information from the examples in the literature, regarding the biotechnological tools those could be useful for the overproduction of health-promoting biochemicals in the medicinal plants. Gene level modification is all about creating improved variety of plants that are highly resistant to pests and pesticides or contain higher levels of nutrients than conventional plants. Plant secondary metabolites constitute an exciting and vital aspect of research, due to their chemical diversity, varied biological functions and pharmacological activities. Gene modification, through Agrobacterium mediated trans-formation, RNA interference or CRISPER/Cas9, has opened avenues of improvement in medicinal plants and provide an alternative production system of pharmaceutically important secondary metabolites for their commercial exploitation.
INTRODUCTION
Plants synthesize innumerable small phytomolecules, known metabolites via integrated complex interconnected enzyme-mediated biosynthetic pathway. 1 Plants primarily synthesize two types of metabolites: The primary metabolites, which are vital for the survival of the organisms and any change in their synthesis, can lead to harmful manifestation. 2 However, secondary metabolites confer a multitude of adaptive and evolutionary advantages to the plants by performing specialized functions and playing a role in providing quality of life to the producer [ Figure 1 ]. Often, secondary metabolites are associated with defense related, antifeedent, insect attractant and repellent functions. 3, 4 Plants are the richest source for the secondary metabolites, which have medicinal and aromatic properties. According to some estimates, approximately 100,000 such secondary metabolites are known to occur in about 50,000 plant species and more than 4,000 unique metabolic compounds are being found each year from several plant species. [5] [6] [7] [8] For thousands of years, we have been dependent on natural plant products for human healthcare in the form of drugs, antioxidants, flavors, fragrances, dyes, insecticides and pheromones. 9, 10 The global plant-derived product market is expected to gain momentum over the coming years. 11 Firstly, due to the low cost of herbal medicines compared to allopathy and secondly, due to fewer side effects and no overdose toxicity, that are so common in the case of synthetic drugs. There is an increasing inclination of consumers towards traditional medicines. Consequently, global herbal medicine (Ayurveda, Unani and Traditional Chinese Medicine) market size which was valued at USD 71.19 billion in 2016, is expected to reach $ 111 billion by the end of 2023. This growth in market, is due to increasing demand and can only be met through intensive research investments and funding, which will support constant supply of these herbal products in near future. 12 Despite such a substantial increase in demand for nutraceuticals, the associated growth in medicinal crop cultivation has marginally increased. The reasons may be identified as (1) low concentration of targeted phytomolecules in specific plant tissues, (2) technological neglect in growing medicinal crops, (3) conversion of habitats of medicinal plants to food or cash crop cultivation, (4) conventional breeding techniques do not provide desirable level of improvement due to sterility, long generation time and complex biosynthetic pathways involved. 13, 14 In this review, we have compiled the useful information after extensive literature survey concerning the biotechnological tools and those could be useful for the overproduction of health-promoting biochemicals in the medicinal plants.
GENE LEVEL MODIFICATION THROUGH METABOLIC ENGINEERING
To increase the production of (a group of) compound(s), directed and user manipulation of metabolic pathways at gene level in a living system can be performed by manipulating transporters along with enzymatic and regulatory functions of the cell 15, 16 and eggplant fruits are of different shape and sizes that render them as an ideal system for metabolic engineering. Here, we have developed an agroinfiltration protocol for the transient expression of a gene in the eggplant fruit using GUS bearing; pCAMBIA1304 vector. Thereafter, to prove the effectiveness of the developed protocol, we have used the eggplant hydroxycinnamoyl CoA-quinate transferase (SmHQT Metabolic engineering is now used to improve medicinal plants to meet the requirements of increased human Journal of Young Pharmacists, Vol 11, Issue 4, Oct-Dec, 2019 health. 17 Metabolic engineering may be approached through, overexpression or upregulation of gene(s) specific to rate-limiting steps in the pathway and by blocking competitive pathways to reduce degradation of the product of interest. 18 There have been efforts to alter the expression of some regulatory genes that control multiple genes in the biosynthetic pathway, like down regulation of zeaxanthin epoxidase gene by antisense and co-suppression inhibition, which resulted in an accumulation of zeaxanthin. 19 By means of metabolic engineering, selective novel metabolites can be produced, the target of secondary metabolite can be overproduced and proportion of toxic and unwanted chemicals can be reduced. The strategy to amplify the metabolic flux of a pathway can be achieved by increasing the composition of the enzyme involved in the rate-limiting step of the pathway. 20 With progress in tissue culture techniques, combined with development in genetic engineering and bioinformatics, have opened a panorama for large-scale and improved production of secondary metabolites with pharmaceutical and nutritional value. 21
STRATEGIES TO INDUCE GENE LEVEL MODIFICATION
Various genetic manipulation techniques and technologies have been applied in plants, such as overexpression of transgenes, expressions of multiple transgenes, gene silencing and overproduction of bioactive plant natural products. 22, 23 To mention a few, three most commonly used methods are discussed below:
AGROBACTERIUM MEDIATED TRANSFORMATION
For transferring useful genes into crop plants, Agrobacterium-mediated gene transfer is the most frequently used method of transformation, either in differentiated plant cells or into undifferentiated cells of callus [ Figure 2 ]. This method uses the natural ability of Agrobacterium to infect and transfer genes to the plant cells. The success of this method relies on many factors, like type of target cells or tissues and its competence for regeneration and transformation, efficiency of DNA delivery, stringency of system used for selection of transformed cells and the ability to recover fertile transgenic plants. 24] Agrobacterium tumefaciens mediated transformation systems in medicinal crops is pertinent to highly efficient and rapid transgenic plant production for desirable traits for cultivation. Increased yield, biotic and abiotic stress tolerance, hyper-production of one or more desirable secondary metabolite or other phytochemicals, suppression of synthesis of one or more undesirable phytochemical, suppression of one or more native genes, metabolic engineering of endogenous pathways, incorporation of genetic traits (genes) of new or non-native metabolic pathways in the plant etc., 25, 26 A. rhizogenes-based transformation is another potential system for manipulation in biosynthesis of secondary metabolites, mainly in roots of medicinal plants. Ri transformed hairy root cultures shows rapid growth, reduced apical dominance, high branching and increased large scale production of targeted secondary metabolites. 27 
RNA INTERFERENCE
Out of many possible ways of gene modification, RNAi approach can be used, in which accumulation of preceding intermediates can be enhanced by degrading the mRNA expression of the subsequent gene(s) in that particular pathway. RNA interference is a powerful tool to comprehend gene function in both plants and animals. Gene silencing is considered as suppression of the expression of a gene at either transcription or translation level. 28 In this approach, particular mRNA is degraded, which is associated with double-stranded DNA. This type of gene silencing is considered as cosuppression or posttranscriptional gene silencing in plants. 29, 30 Although RNA interference is a potent tool in gene silencing, still it has not been exploited much for manipulating plant secondary metabolite production. 31 Using this method the production of pharmaceutically important secondary metabolites in plants, for instance; Papaver somniferum, P. ginseng, A. annua and W. somnifera. 32, 33 Using this method researchers have developed a process for production of non-narcotic alkaloid, reticuline in opium poppy, which is more potent than morphine. Here gene encoding Codeinone Reductase (COR), a key enzyme of morphine biosynthetic pathway was silenced. Increased level of reticuline was observed through feedback mechanism. 34 This technique has proved to be a breakthrough in molecular biology research and has led to establishment of RNAi focused biotechnology companies. This method of gene silencing is quite simple and is a potent tool for large scale functional analysis in various organisms. 35 RNA interference is a multistep process that includes enzymes like Drosha, DICER and RISC. Long dsRNA and hairpin molecules occur naturally inside cells and from here the mechanism of RNAi initiates. All dsRNAs and hairpin RNAs are processed with the help of an RNase IIIlike enzyme DICER into 21 to 25 nucleotides duplex. Small siRNAs and miRNAs join with a multi-nuclease complex RISC (RNA induced silencing complex) leading to degradation of homologous mRNAs. 36 ATP is required for the formation of RISC on siRNA, but once it is established, it can mediate robust cleavage even in absence of ATP. One strand of siRNA is integrated into RISC complex, it is considered as guide strand and the complementary strand is known as passenger strand, degraded as a RISC complex substrate in the process. RISC has a catalytic component called as AGO protein that helps to silent target mRNA. 37 Most importantly, it is the 5' end of guide strand that acts as a ruler for cleavage of RNA target. RISC complex with guide RNA is targeted to target mRNA, where mRNA is either silenced by forming a double-stranded duplex or degraded by RISC complex as shown in Figure 3 .
CRISPR/CAS9
Some specific bacteria and archaea employ, proteins associated with CRISPR (clustered regularly interspaced short palindromic repeats), to act as an element of their pathogen defence system. 38 The host cell incorporates the fragments of the pathogen's DNA into its CRISPR loci, hence, attains resistance to a pathogenic organism, subsequently transcribed as CRISPR RNA (crRNA) and guides the degradation of pathogen transcripts. 39 The non-specific Cas9 nuclease and a single guide RNA present in the CRISPR/Cas9 tool directs Cas9 to the target gene loci and then craft double-strand breaks [ Figure 4 ]. The consequent repair process creates insertion or deletion mutations. 40 Consequently the plant's native genomic repertoire can be effectively harnessed by employing precise alteration in DNA sequences. The foremost concern is the off-target cleavage by Cas9, this is evaded by selecting exclusive target site, using various tools available like CRISPR-Plant, GT-scan, CRISPR direct, Benchling, Cas-OFFinder, etc. [41] [42] [43] [44] [45] For identifying specific rate-limiting enzyme responsible for metabolic flux in a biosynthetic pathway, RNAi proves to be an efficient and valuable approach, but non-specific gene silencing can occur at a high rate due to sequence homology. This can lead to degradation of non-target transcripts. Using the CRISPR/Cas9 system as a gene knock-out technology, it becomes less likely to experience non-specific targeting since, the small sequences are uniquely designed which are not more that 20-50 bp length. 46 The advantage of using metabolic engineering techniques like RNA interference or CRISPR/Cas vectors is that they induce site-specific mutations without the requirement of foreign DNA. In view of the fact that no transgene is used to modify plants, they are not included in the category of GMO, thereby easing out the process of biosafety concerns. 47 Examples from the literature related metabolic engineering are provided in Table 1 .
USE OF BIOINFORMATICS
Integration of system biology knowledge with traditional genetic engineering technique helps by cutting redundant exercise at the wet lab level. By using bioinformatics tools, we can easily refine our targets (genes/enzymes) for application in metabolic engineering process. 72 Bioinformatics tools can be applied to evaluate various proteins involved in secondary metabolism pathways as explained in Figure 5 . The secondary structure prediction can help us by elucidating the random coils which are the main components of the protein structure. Further, the model hence developed will serve as a valuable theoretical information which, can provide the physicochemical and structural data in order to functionally assess the target protein. Moreover, biotechnological studies can use the obtained results to manipulate the biosynthesis pathways, for higher secondary metabolite production. 73, 74 
SCIENTIFIC CHALLENGES AND ISSUES TO BE ADDRESSED
To verify the predicted agronomic traits, the ecological relevance of lab trials should be tested under field conditions. It has been observed that genetically modified plants in field trial experience a large number of factors that can influence their predicted performance like, increased pathogen pressure, weather variance and the difference in soil characteristics; which otherwise is not faced by these plants under laboratory conditions. 75 One such instance goes with transgenic pea plant, which was not able to efficiently express antifungal proteins against Fusarium spp. Additionally, variation in expression of gene was found in different parts of the plant. 76 As also mentioned in other studies, expression of chitinase gene in Nicotina sylvestris did not increase resistance to Cercospora nicotiana; 77 neither expression of PGIP2 gene in wheat reduced the symptoms of Claviceps 19 purpurea; 78 additionally expression of β-1,3 glucanase in alfalfa did not decrease the severity of chitin containing fungus. 79 and a rice basic chitinase (RCH10 Moreover, identification of potentially useful genes to be engineered in plants is another huge task which greatly varies amongst plant species. Transformation and genome editing face additional challenges of extremely low transformation frequency and very few cell lines have the appropriate acquired the desired genetic expression. 80
COMMERCIAL DEVELOPMENT
Regardless of the victory of specific plant secondary metabolites substances as drugs, their restricted accessibility and challenging synthesis often make them only leads and not candidate drugs for scientists and pharmaceutical companies in the quest for new therapeutic hits. 81 With the increasing economic significance of secondary plant metabolites, enormous amount of efforts are put into research to understand and Journal of Young Pharmacists, Vol 11, Issue 4, Oct-Dec, 2019 [51] Coffea canephora CaMXMT1 Reduction in caffeine content by 70% RNA interference Ogita et al. 2003 [52] Glycine max Flavanone 3-hydroxylase (F3H) gene and flavone synthase II (GmFNSII)
Enhance isoflavone production RNA interference Jiang et al. 2014 [53] Nicotiana tabacum Cytochrome P450, CYP82E2 family Conversion of nicotine to nornicotine RNA interference Siminszky et al. 2005 [54] Nicotiana benthamiana
Glycosyltrans-ferase gene Production of recombinant proteins lacking β-1,2-xylose and core α-1,3fucose CRISPR/Cas9 Jansing et al. 2018 [55] Panax ginseng Squalene synthase;
Triterpene biosynthesis
PgSS1 gene Agrobacterium-mediated transformation Seo et al. 2005 [56] Panax ginseng Ginsenoside and phytosterol biosynthesis Squalene epoxidase gene RNA interference Han et al. 2010 [57] Panax ginseng Triterpenoid saponins Protopanaxadiol 6-hydroxylase gene RNA interference Park et al. 2016 [58] Panax notoginseng triterpenoid saponins biosynthesis. 3-hydroxy-3-methylglutaryl CoA reductase (PnHMGR) and squalene synthase (PnSS)
Agrobacterium-mediated transformation
Deng et al. 2017 [59] Panax quinquefolius Biosynthesis of protopanaxadiol-group ginsenosides UDP-glucosyltransferase gene RNA interference Lu et al. 2017 [60] Panax quinquefolius Ginsenoside synthesis Down-regulation of UDP-Glycosyltransferase gene
RNA interference
Lu et al. 2017 [61] Papaver somniferum Salutaridinol 7-O-acetyltransferase (SalAT)
Alkaloid salutaridine at up to 23% RNA interference Allen et al. 2008 [62] Papaver somniferum COR 1, COR2 Morphine replacement by increase in level of nonarcotic alkaloid reticuline RNA interference Allen et al. 2004 [63] Papaver somniferum Benzylisoquinoline alkaloid (BIAs) biosynthesis (R, S)-reticuline 7-O-methyltransferase (7OMT) and 3′-hydroxyl-Nmethylcoclaurine 4′-O-methyltransferase (4′OMT2)
CRISPR/Cas9
Alagoz et al. 2016 [64] Salvia miltiorrhiza Tanshinone biosynthesis knock out the committed diterpene synthase gene (SmCPS1)
Li et al. 2017 [65] Salvia miltiorrhiza phenolic acid biosynthetic pathway rosmarinic acid synthase gene (SmRAS) CRISPR/Cas9 Zhou et al. 2018 [66] Solanum lycopersicum [70] Withania somnifera Cycloartenol synthase (CAS) Enhanced level of withanolides RNA interference Mishra et al. 2016 [71] manipulate the biosynthetic pathways using various chemical, physiological and biotechnological methods. 82 To improve productivity and evaluate improvement in secondary metabolites production from plant system, a holistic approach needs to be adopted, with more advanced technologies. These new technological developments can provide enhanced opportunities for continued usefulness of medicinally important plants to be developed as a renewable source of medicinal compounds. With increased intensification of efforts in the field of biotechnology, successful commercial methods of specific and valuable plant chemicals production can be developed. 83 Bioactive compounds are produced either directly or indirectly by a considerable number of pharmaceutical industries at a larger scale. With evolving techniques of molecular biology, studies on production of transgenic cultures and subsequent effect on expression and regulation of biosynthetic pathways, is stride in the direction of making cell cultures by and significant more applicable for commercial production of secondary metabolites. 84, 85 A combined effort of metabolic engineering and bioinformatics techniques can solve the problem of limited availability of bioactive compounds from medicinal plants. By combining plant cell culture technologies of plant biotechnology with metabolic engineering, transformed cells in reactors under controlled conditions can be a replacement of field-grown plants, for plant secondary metabolite production. 86, 87 Another improvement towards the development of new fermentation processes for industrialized production of natural plant products is based on metabolic engineering of microorganisms for the desired biosynthetic pathway. This method has several advantages like its economic feasibility, environmentally friendly, low energy requirements and reduced waste emissions. 88 In the extension of the stated method, flavonoid production has been enhanced by systematically fine-tuning the central metabolic pathways based on a CRISPR gene editing system in Escherichia coli and thereby efficiently channeling carbon flux toward malonyl-CoA without significantly altering the final biomass accumulation. 89 Synthetic bioengineering of Rhodotorula glutinis phenylalanine/ tyrosine ammonia lyase has also been developed to produce a phenylpropanoid acid precursor in Escherichia coli, to improve trans-cinnamic acid and p-coumaric acid production. 90
FUTURE PROSPECTS
With the addition of sophisticated bioinformatics and metabolomic tools based on biochemical, genetic, environmental and developmental parameters, it will offer improvement in understanding of primary and secondary metabolic pathways in medicinal plants. Moreover The potential of pharmacologically active secondary plant metabolites is often restricted by low yield and availability of the producing plant.
To add to the woes, chemical synthesis of these complex compounds is often too expensive and also do not provide with the correct structure or chirality of the compound. Plant cell culture offers an efficient strategy to overcome these limitations. Additionally, plant tissue culture proves to be an efficient method for continuous production of secondary metabolites and engineered molecules from medicinally important plants. Methods of gene editing can further improve the technique.
CONCLUSION
Metabolic engineering procedures reported in recent experiments illustrate that when the rate-limiting steps of the biosynthetic pathway are identified and the respective genes are cloned, the accurate regulation towards overproduction of desired medicinal product is feasible commercially. With expansion of boundaries of metabolic engineering it might also be possible to fabricate array of new compounds in plants or their respective tissue cultures by introducing foreign genes coding for enzymes, which can convert existing compounds to newer products and open means for more unique pathways.
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